Status:
COMPLETED
Study Evaluating Pneumococcal Meningitis in the Paediatric Population in Spain Four Years After the Marketing of Prevenar.
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Pneumococcal Meningitis
Eligibility:
All Genders
Up to 14 years
Brief Summary
The aim of this study is to determine the prevalence of pneumococcal meningitis in the paediatric population in Spain four years after the marketing of Prevenar. Also secondary objectives are: 1) to d...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All children from 0 up to 14 years with diagnosis of confirmed or probable pneumococcal meningitis or with diagnosis of suspected bacterial meningitis without bacterial or viral isolation will be included into the study.
Exclusion
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00227214
Start Date
January 1 2004
End Date
December 1 2006
Last Update
June 28 2010
Active Locations (39)
Enter a location and click search to find clinical trials sorted by distance.
1
A Coruña, Spain
2
Alcalá de Henares, Spain
3
Alcorcón, Spain
4
Arrasate / Mondragón, Spain